1. Home
  2. SKYW vs GPCR Comparison

SKYW vs GPCR Comparison

Compare SKYW & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SkyWest Inc.

SKYW

SkyWest Inc.

HOLD

Current Price

$111.38

Market Cap

3.5B

ML Signal

HOLD

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$48.36

Market Cap

3.4B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKYW
GPCR
Founded
1972
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.4B
IPO Year
1994
2023

Fundamental Metrics

Financial Performance
Metric
SKYW
GPCR
Price
$111.38
$48.36
Analyst Decision
Buy
Strong Buy
Analyst Count
3
12
Target Price
$123.67
$103.17
AVG Volume (30 Days)
440.5K
531.6K
Earning Date
04-23-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
33.20
N/A
EPS
5.04
N/A
Revenue
$2,971,963,000.00
N/A
Revenue This Year
$8.35
N/A
Revenue Next Year
$3.55
N/A
P/E Ratio
$21.22
N/A
Revenue Growth
N/A
N/A
52 Week Low
$77.89
$15.80
52 Week High
$123.94
$94.90

Technical Indicators

Market Signals
Indicator
SKYW
GPCR
Relative Strength Index (RSI) 65.01 47.79
Support Level $95.93 $43.76
Resistance Level N/A $57.15
Average True Range (ATR) 3.86 2.67
MACD 0.77 -0.49
Stochastic Oscillator 84.44 40.83

Price Performance

Historical Comparison
SKYW
GPCR

About SKYW SkyWest Inc.

SkyWest Inc offers commercial air services in the United States, Canada, Mexico, and the Caribbean. Additionally, it leases aircraft to capable users to help generate revenue. SkyWest generally provides regional flights and utilizes smaller, lower-cost aircraft to carry passengers who book tickets through partner airlines. It partners with carriers to fly and operate aircraft for a fee and may use the carriers' brands and ground support to coordinate marketing and transport passengers. The company has two reportable segments: SkyWest Airlines and SWC, which generate maximum revenue, and SkyWest Leasing activities.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: